Tin tức & Cập nhật
Xem bài viết Gan
Xem
Direct-acting antivirals improve survival in patients with HCV-related HCC
A recent study in UK has shown a significant proportion of patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) initiating direct-acting antiviral (DAA) therapy, resulting in improvements in sustained virological response (SVR) rates.
Direct-acting antivirals improve survival in patients with HCV-related HCC
22 Jun 2026
Seladelpar improves liver outcomes in cirrhosis patients with PBC, portal hypertension
Treatment with seladelpar for 4 years yields consistent biochemical efficacy, with no new safety concerns, among patients with cirrhosis and primary biliary cholangitis (PBC), as shown by interim results from the open-label ASSURE study.
Seladelpar improves liver outcomes in cirrhosis patients with PBC, portal hypertension
21 Jun 2026
FMT reduces alcohol cravings, relapse rates in patients with ALD
Faecal microbiota transplantation (FMT) significantly improves alcohol abstinence and reduces relapse episodes for up to 6 months in patients with alcohol-related liver disease (ALD) and alcohol use disorder (AUD), as shown in a recent study presented at EASL 2026.
